TrialEuropean heart journal. Cardiovascular pharmacotherapy2025

An aspirin-free strategy for percutaneous coronary intervention in patients with diabetes: a pre-specified subgroup analysis of the STOPDAPT-3 trial.

Ko Yamamoto et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.